DK1633374T3 - Sammensætning af alkandicarboxylsyrer og et farmaceutisk aktivt stof - Google Patents
Sammensætning af alkandicarboxylsyrer og et farmaceutisk aktivt stofInfo
- Publication number
- DK1633374T3 DK1633374T3 DK04734822T DK04734822T DK1633374T3 DK 1633374 T3 DK1633374 T3 DK 1633374T3 DK 04734822 T DK04734822 T DK 04734822T DK 04734822 T DK04734822 T DK 04734822T DK 1633374 T3 DK1633374 T3 DK 1633374T3
- Authority
- DK
- Denmark
- Prior art keywords
- composition
- active substance
- pharmaceutically active
- alkanedicarboxylic acids
- hydrogen atom
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 241001303601 Rosacea Species 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 abstract 1
- 150000002460 imidazoles Chemical class 0.000 abstract 1
- 201000004700 rosacea Diseases 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10326722 | 2003-06-10 | ||
| PCT/EP2004/005668 WO2004108143A1 (de) | 2003-06-10 | 2004-05-26 | Zusammensetzung aus alkandicarbonsäuren und einem pharmazeutischen wirkstoff |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1633374T3 true DK1633374T3 (da) | 2007-12-03 |
Family
ID=33495022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04734822T DK1633374T3 (da) | 2003-06-10 | 2004-05-26 | Sammensætning af alkandicarboxylsyrer og et farmaceutisk aktivt stof |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1633374B1 (da) |
| JP (1) | JP2006527219A (da) |
| AT (1) | ATE369866T1 (da) |
| CY (1) | CY1107006T1 (da) |
| DE (1) | DE502004004660D1 (da) |
| DK (1) | DK1633374T3 (da) |
| ES (1) | ES2293258T3 (da) |
| PL (1) | PL1633374T3 (da) |
| PT (1) | PT1633374E (da) |
| WO (1) | WO2004108143A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2875404B1 (fr) * | 2004-09-17 | 2008-10-03 | Galderma Res & Dev | Composition pharmaceutique pour le traitement de la rosacee |
| GB0513058D0 (en) * | 2005-06-27 | 2005-08-03 | Sandoz Ag | Organic compounds |
| DE102010021671A1 (de) | 2010-05-27 | 2011-12-01 | Intendis Gmbh | Azelainsäurehaltige Formulierung mit Pigmentzusatz |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4837378A (en) * | 1986-01-15 | 1989-06-06 | Curatek Pharmaceuticals, Inc. | Topical metronidazole formulations and therapeutic uses thereof |
| US4713394A (en) * | 1986-01-17 | 1987-12-15 | Thornfeldt Carl R | Treatment of nonacne inflammatory and infectious dermatoses and hair loss |
| ATE210438T1 (de) * | 1997-11-19 | 2001-12-15 | Schering Ag | Zusammensetzung mit azelainsäure |
| CN1393221A (zh) * | 2001-06-22 | 2003-01-29 | 姜涛 | 一种治疗痤疮的药液 |
-
2004
- 2004-05-26 DK DK04734822T patent/DK1633374T3/da active
- 2004-05-26 EP EP04734822A patent/EP1633374B1/de not_active Expired - Lifetime
- 2004-05-26 DE DE502004004660T patent/DE502004004660D1/de not_active Expired - Lifetime
- 2004-05-26 ES ES04734822T patent/ES2293258T3/es not_active Expired - Lifetime
- 2004-05-26 PL PL04734822T patent/PL1633374T3/pl unknown
- 2004-05-26 PT PT04734822T patent/PT1633374E/pt unknown
- 2004-05-26 AT AT04734822T patent/ATE369866T1/de active
- 2004-05-26 JP JP2006515796A patent/JP2006527219A/ja active Pending
- 2004-05-26 WO PCT/EP2004/005668 patent/WO2004108143A1/de not_active Ceased
-
2007
- 2007-11-14 CY CY20071101468T patent/CY1107006T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL1633374T3 (pl) | 2008-03-31 |
| EP1633374A1 (de) | 2006-03-15 |
| PT1633374E (pt) | 2007-11-14 |
| ATE369866T1 (de) | 2007-09-15 |
| CY1107006T1 (el) | 2012-09-26 |
| JP2006527219A (ja) | 2006-11-30 |
| WO2004108143A1 (de) | 2004-12-16 |
| EP1633374B1 (de) | 2007-08-15 |
| ES2293258T3 (es) | 2008-03-16 |
| DE502004004660D1 (de) | 2007-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20061432L (no) | N3 alkylerte benzimidazolederivater som MEK-inhibitorer | |
| LU92300I2 (fr) | Regorafenib et ses sels pharmaceutiquement acceptables (STIVARGA) | |
| BR122018007328B8 (pt) | composto, composição farmaceutica e uso do dito composto | |
| UA107324C2 (uk) | Похідні 1,2,3-триазолу для застосування як інгібіторів стеароїл-coa десатурази | |
| IS6852A (is) | Efnasambönd | |
| PE20020476A1 (es) | Derivados de glucopiranosiloxibencilbenceno y composiciones farmaceuticas que comprenden los mismos | |
| NZ580226A (en) | Dimer compounds as inhibitors of iap | |
| PE20100562A1 (es) | Derivados policiclicos de indazol como inhibidores de erk | |
| CY1109519T1 (el) | Κεκορεσμενες και ακορεστες 3-πυριδυλο-βενζοκυκλοαλκυλομεθυλαμινες για τη θεραπεια πονων, καταθλιψεων και καταστασεων φοβου | |
| NO20060416L (no) | Ny anvendelse I | |
| CY1109962T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας | |
| NO20055977L (no) | Nye benzimidazolderivater | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| MY143568A (en) | 11b-hsd1 inhibitors for the treatment of diabetes | |
| BRPI0407968A (pt) | derivados de oxamida úteis como inibidores de raf-quinase | |
| NO20050667L (no) | N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes | |
| CY1107006T1 (el) | Συνθεση απο αλκανιοδικαρβονικα οξεα και μια φαρμακευτικη ουσια | |
| EA201070603A1 (ru) | Лекарственное средство, активное в отношении невропатической боли | |
| BR0311365A (pt) | Sal de adição de ácido farmaceuticamente aceitável, processo para a preparação de um sal de adição de ácido formulação farmacêutica, uso de um sal de adição de ácido, e, método de tratamento de uma condição onde a inibição da trombina é requerida | |
| DE60312682D1 (de) | Methode zur behandlung von rosacea durch topische verabreichung eines cyclohexanderivats | |
| CY1106903T1 (el) | Φαρμακευτικος συνδυασμος για τη θεραπεια της σπαστικοτητας και/ή του πονου | |
| ATE432262T1 (de) | Pyrazolphenylderivate als ppar-aktivatoren | |
| ATE540920T1 (de) | Aminobenzocycloheptenderivate, verfahren zu deren herstellung und deren verwendung in der therapie | |
| SE0403117D0 (sv) | New compounds 1 | |
| SE0301442D0 (sv) | Diarylmethylidene piperidine derivatives, preparations therof and uses thereof |